Posted by Michael Wonder on 04 Jul 2022
TLV reconsiders Orkambi's subsidy
4 July 2022 - TLV has started a reconsideration of the drug Orkambi in light of the fact that the treatment cost is now higher than it was at the time of the decision in 2018.
Orkambi has been part of the high-cost protection since 1 July 2018.
